SCHEMBL23572370

SCHEMBL23572370

O=C(c1cccc(C(=C(c2ccccc2)c2ccccc2)c2cccc(C(=O)c3ccccn3)c2)c1)c1ccccn1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.73
▸ HSD17B14 Q9BPX1 1/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ NAPRT Q6XQN6 1/20 0.53
▸ P4HTM Q9NXG6 1/20 0.53
▸ KCNK3 O14649 1/20 0.53
▸ KCNK9 Q9NPC2 1/20 0.53
▸ ATM Q13315 1/20 0.52
▸ TDP1 Q9NUW8 1/20 0.52
▸ CES2 O00748 1/20 0.50
▸ CES1 P23141 1/20 0.50
▸ ALDH1A1 P00352 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ PKM P14618 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ AGTR1 P30556 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL398165 0.85 KMT2A (1.00) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL29373829 0.85 KMT2A (1.00) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL22172012 0.85 KMT2A (0.71) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL28005707 0.83 KMT2A (0.96) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL28015961 0.83 KMT2A (0.96) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL12441772 0.81 KMT2A (0.66) KMT2AHSD17B14LMNAKCNK3KCNK9
SCHEMBL30659509 0.81 KMT2A (0.66) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL3836551 0.81 KMT2A (0.66) KMT2AHSD17B14KCNK3KCNK9CES2
SCHEMBL8586217 0.81 KMT2A (0.66) KMT2AHSD17B14L3MBTL1LMNANAPRT
SCHEMBL7078280 0.81 KMT2A (0.66) KMT2AHSD17B14L3MBTL1LMNANAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024427-A1 PLATINUM METAL COMPLEX AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE GUANGDONG AGLAIA OPTOELECTRONIC MATERIALS CO., LTD (CN) 2023-01-26 — — US disclosed
WO-2021120742-A1 PLATINUM METAL COMPLEX AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE 广东阿格蕾雅光电材料有限公司 2021-06-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024427-A1 PLATINUM METAL COMPLEX AND USE THEREOF IN ORGANIC ELECTROLUMINESCENT DEVICE OXA1L, LAGE3, SLCO4C1 KMT2A 4028/4885HSD17B14 2320/4885L3MBTL1 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback